Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Proguanil 100mg / Atovaquone 250mg tablets
0504010U0AAAAAA
|
Proguanil hydrochloride/atovaquone | Proguanil hydrochloride with atovaquone | Infections | 96 |
|
Malarone 250mg/100mg tablets
0504010U0BBAAAA
|
Malarone | Proguanil hydrochloride with atovaquone | Infections | 58 |
|
Malarone Paediatric 62.5mg/25mg tablets
0504010U0BBABAB
|
Malarone | Proguanil hydrochloride with atovaquone | Infections | 29 |
|
Proguanil 25mg / Atovaquone 62.5mg tablets
0504010U0AAABAB
|
Proguanil hydrochloride/atovaquone | Proguanil hydrochloride with atovaquone | Infections | 29 |
|
Maloff Protect 250mg/100mg tablets
0504010U0BEAAAA
|
Maloff Protect | Proguanil hydrochloride with atovaquone | Infections | 1 |
|
Mafamoz 250mg/100mg tablets
0504010U0BDABAA
|
Mafamoz | Proguanil hydrochloride with atovaquone | Infections | No data available |
|
Mafamoz 62.5mg/25mg tablets
0504010U0BDAAAB
|
Mafamoz | Proguanil hydrochloride with atovaquone | Infections | No data available |
|
Reprapog 250mg/100mg tablets
0504010U0BCABAA
|
Reprapog | Proguanil hydrochloride with atovaquone | Infections | No data available |
|
Reprapog 62.5mg/25mg tablets
0504010U0BCAAAB
|
Reprapog | Proguanil hydrochloride with atovaquone | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.